Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach
Open Access
- 28 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (8), 1696-1711
- https://doi.org/10.1093/jac/dkr195
Abstract
The development of daptomycin resistance in Staphylococcus aureus is associated with clinical treatment failures. The mechanism(s) of such resistance have not been clearly defined. We studied an isogenic daptomycin-susceptible (DAPS) and daptomycin-resistant (DAPR) S. aureus strain pair (616; 701) from a patient with relapsing endocarditis during daptomycin treatment, using comparative transcriptomic and proteomic techniques. Minor differences in the genome content were found between strains by DNA hybridization. Transcriptomic analyses identified a number of genes differentially expressed in important functional categories: cell division; metabolism of bacterial envelopes; and global regulation. Of note, the DAPR isolate exhibited reduced expression of the major cell wall autolysis gene coincident with the up-regulation of genes involved in cell wall teichoic acid production. Using quantitative (q)RT–PCR on the gene cadre putatively involved in cationic peptide resistance, we formulated a putative regulatory network compatible with microarray data sets, mainly implicating bacterial envelopes. Of interest, qRT–PCR of this same gene cadre from two distinct isogenic DAPS/DAPR clinical strain pairs revealed evidence of other strain–dependent networks operative in the DAPR phenotype. Comparative proteomics of 616 versus 701 revealed a differential abundance of proteins in various functional categories, including cell wall-associated targets and biofilm formation proteins. Phenotypically, strains 616 and 701 showed major differences in their ability to develop bacterial biofilms in the presence of the antibacterial lipid, oleic acid. Compatible with previous in vitro observations, in vivo-acquired DAPR in S. aureus is a complex, multistep phenomenon involving: (i) strain-dependent phenotypes; (ii) transcriptome adaptation; and (iii) modification of the lipid and protein contents of cellular envelopes.Keywords
This publication has 103 references indexed in Scilit:
- Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus : Evidence for Multiple Resistance MechanismsAntimicrobial Agents and Chemotherapy, 2010
- Staphylococcal superantigen-like genes, ssl5 and ssl8, are positively regulated by Sae and negatively by Agr in the Newman strainFEMS Microbiology Letters, 2010
- Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureusThe Journal of Infectious Diseases, 2009
- Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In VivoAntimicrobial Agents and Chemotherapy, 2009
- Microbiological and Genotypic Analysis of Methicillin-Resistant Staphylococcus aureus BacteremiaAntimicrobial Agents and Chemotherapy, 2008
- Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane DepolarizationAntimicrobial Agents and Chemotherapy, 2008
- Sensor complexes regulating two-component signal transductionCurrent Opinion in Structural Biology, 2007
- Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencingProceedings of the National Academy of Sciences, 2007
- Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometryNature Methods, 2007
- Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006